PA-EXONE
11.11.2021 14:33:09 CET | Business Wire | Press release
The ExOne Company (Nasdaq: XONE), the global leader in industrial sand and metal 3D printers using binder jetting technology, today announced that the Schunk Group, an international technology company featuring products made of high-tech materials, including sintered metals, has purchased an X1 25Pro large metal binder jetting system.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211111005667/en/
The new X1 25Pro metal printing system will be installed and used in the Schunk Sinter Metals location in Thale, Germany, to provide serial production of sintered metal parts to automotive, aerospace, medical, and other customers throughout Europe – starting with 316L stainless steel and later expanding to other materials.
“We believe 3D printing is the technology of the future, and we will use our binder jetting system to develop technologies and parts that go beyond what we can provide with traditional sintered metal components,” said Tobias Franz Heusel, Global Account Manager at Schunk.
Schunk plans to integrate its ExOne metal binder jetting technology into its industrial ecosystem that already includes other methods of 3D printing producing parts with different materials such as copper, stainless steel and low alloyed steel, as well as conventional manufacturing processes such as axial pressing and metal injection molding. “We believe binder jetting offers four primary advantages. In addition to speed and freedom of design, the ability to produce large volumes with 3D printing and a large selection of materials is fairly unique among 3D printing processes,” Heusel added.
Schunk selected ExOne as its binder jet partner, largely because of the company’s extensive history as the commercial pioneer and market leader in metal binder jetting. Over its history, ExOne has launched more than 10 commercial metal binder jetting systems.
“We are proud to partner with Schunk to provide ExOne binder jet 3D printing services in the European market,” said Eric Bader, Managing Director, ExOne, EMEA. “Schunk’s services will complement our own ExOne Adoption Center (EAC) in Gersthofen, where we will provide benchmarks to customers interested in purchasing machines.”
Details about Schunk’s move into binder jet 3D printing can be found at https://bit.ly/SchunkX1en
What is Binder Jet 3D Printing?
ExOne’s binder jet 3D printing transforms powdered materials – metal, sand or ceramic – into highly dense and functional precision parts at high speeds.
An industrial printhead selectively deposits a binder into a bed of powder particles creating a solid part one thin layer at a time. When printing metals, the final bound metal part must be sintered in a furnace to fuse the particles together into a solid object. ExOne now delivers high densities of greater than 97% for most metals, in line with Metal Injection Molding or gravity castings.
Binder jet 3D printing technology is viewed as a desirable and sustainable production method, largely because of its high speed, low waste and cost, as well as material flexibility.
About ExOne
ExOne (Nasdaq: XONE) is the pioneer and global leader in binder jet 3D printing technology. Since 1995, we’ve been on a mission to deliver powerful 3D printers that solve the toughest problems and enable world-changing innovations. Our 3D printing systems quickly transform powder materials — including metals, ceramics, composites and sand — into precision parts, metalcasting molds and cores, and innovative tooling solutions. Industrial customers use our technology to save time and money, reduce waste, improve their manufacturing flexibility, and deliver designs and products that were once impossible. As home to the world’s leading team of binder jetting experts, ExOne also provides specialized 3D printing services, including on-demand production of mission-critical parts, as well as engineering and design consulting. Learn more about ExOne at www.exone.com or on Twitter at @ExOneCo. We invite you to join with us to #MakeMetalGreen™.
Schunk Group
The Schunk Group is a global technology company. The company is a leading supplier of products made of high-tech materials – such as carbon, technical ceramics and sintered metal – as well as machines and systems – from environmental simulation and air conditioning to ultrasonic welding and optical machines. The Schunk Group has around 9,000 employees in 29 countries and achieved sales of €1.2 billion in 2020. Learn more at www.schunk-group.com or on LinkedIn @Schunk Group.
With over 90 years of experience in powder metallurgy, the business unit Schunk Sinter Metals is the technology and development partner for the automotive and aerospace industries when it comes to the production of sintered metal parts by axial pressing, metal powder injection molding and additive manufacturing processes. Learn more at www.schunk-mobility.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20211111005667/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TIMELAB Develops OEM/ODM Hair Straightener Reaching 200°C at All Three Measured Points in 15 Seconds17.9.2026 16:00:00 CEST | Press release
Testing at 230 V with a 260°C setting confirmed at least 200°C after 15 seconds at all three measured plate locations (front, center and rear), not just a single point. TIMELAB Co., Ltd., a Japanese beauty-appliance OEM/ODM provider, has developed a hair straightener for OEM/ODM customization for international hair care brands and professional markets. In testing at 230 V with a 260°C setting, all three measured plate locations reached at least 200°C after 15 seconds. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260914187865/en/ Three-Point Plate Testing A European-market development unit with a maximum setting of 260°C was tested at 230 V. Fifteen seconds after power-on, readings at the front, center and rear were 212.5°C, 227.5°C and 200.0°C, respectively. From around 60 seconds onward, temperature differences among the three points narrowed, indicating a stable trend. Precision Temperature Control An NTC sensor inside t
Earnix Brings Agentic AI to the Decisions That Drive Insurance Performance17.9.2026 15:09:00 CEST | Press release
Agent Hub, part of Earnix AIOS, brings more than 25, insurance-specific agents and apps into Earnix’s governed pricing, underwriting, and customer decision solutions- improving workflows and business performance Earnix today announced the introduction of Agent Hub, a curated catalog of insurance-specific AI agents and apps within Earnix AIOS — the AI Orchestration System powering Earnix’s pricing and rating, underwriting, and customer engagement solutions. Agent Hub brings agentic AI directly into these solutions, enabling more intelligent workflows and strengthening the high-stakes decisions that shape pricing, underwriting, customer engagement, growth, and profitability. In an increasingly turbulent insurance environment, the useful life of an insurance decision is getting shorter. Risk and market conditions are changing faster, making growth, profitability, and portfolio performance harder to manage. AI is increasing the speed and scope of what insurers can analyze, recommend, and i
Medisca Launches Global Peptide Division17.9.2026 15:07:00 CEST | Press release
New division brings API-grade peptides and Medisca’s quality-first pharmaceutical expertise to a rapidly evolving area of personalized medicine Medisca today announced the launch of Medisca Peptides, a dedicated global division focused on expanding access to API-grade peptides and building an integrated peptide platform for pharmaceutical and personalized medicine markets worldwide. As the peptide landscape evolves, Medisca is proactively building the capabilities and infrastructure needed to support API-grade peptides within applicable regulatory frameworks. The launch represents a significant long-term commitment to peptides, including the expansion of Medisca’s portfolio, strategic manufacturing relationships, and the pharmaceutical infrastructure needed to support the category’s growth. It also signals Medisca’s ambition to become a leading force in the next generation of peptide innovation. For Medisca, the opportunity is familiar. More than 35 years ago, the company was founded t
Elliptic Launches Its Decode Agent to Answer On-Chain Risk Questions and Shows Its Work17.9.2026 15:00:00 CEST | Press release
Hours of tracing, answered in seconds, with the evidence attached Elliptic, the global leader in on-chain risk, today launched Decode, an AI agent built on Elliptic’s intelligence platform. The Decode agent answers natural-language questions about cryptoasset addresses and their exposure in seconds, and returns the evidence behind every answer. Compliance and investigations teams need answers to questions nobody planned for. Getting them out of the data is now a specialist skill, so the questions wait for someone who has it, or go unasked. Meanwhile illicit actors move at machine speed, and agents are starting to sit on both sides of a payment. General-purpose AI assistants can produce an answer. They cannot show where it came from. A fluent response with nothing behind it cannot be put in front of a second-line reviewer, an auditor, or a regulator. “The market is full of AI that asks to be trusted. That is not good enough when someone asks how you reached a decision,” said Jackson Hul
AMRA Medical Earns TIME’s Highest “Outstanding” Rating in World’s Top HealthTech Companies 202617.9.2026 14:51:00 CEST | Press release
AMRA is the only European company in the Diagnostics segment to receive the highest designation, recognizing its work in MRI-based muscle and fat analysis. The 2026 result builds on AMRA’s inclusion in the inaugural ranking in 2025, when the company received a “Very High” designation. Its advancement to the top category reflects continued progress in scientific excellence and technological innovation, as well as the expanding application of MRI-based biomarkers across research, drug development, and clinical care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260917956850/en/ “Being recognized by TIME and Statista for the second consecutive year and receiving the highest ‘Outstanding’ designation is a meaningful recognition of AMRA’s continued progress,” said Olof Dahlqvist Leinhard, CEO of AMRA Medical. “It reflects the dedication of our team and the strong scientific foundation behind our work. Our mission is to advance t
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
